A Study of Insulin Peglispro and Glargine on Fats in Participants With Type 1 Diabetes

Clinical trial NCT01771250 · COMPLETED

Trial details

NCT number: NCT01771250
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 1

Start date: 2013-10-01
Primary completion: 2014-12-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.